Published articles

Published articles 1 records found  Search took 0.00 seconds. 
1.
22 p, 6.8 MB Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis / Camacho-Toledano, Celia (Hospital Nacional de Parapléjicos-SESCAM) ; Machín-Díaz, Isabel (Hospital Nacional de Parapléjicos-SESCAM) ; Calahorra, Leticia (Hospital Nacional de Parapléjicos-SESCAM) ; Cabañas-Cotillas, María (Hospital Nacional de Parapléjicos-SESCAM) ; Otaegui, David (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Castillo-Triviño, Tamara (Hospital de Donostia (Sant Sebastià, País Basc)) ; Villar, Luisa M (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; García-Domínguez, José Manuel (Hospital General Universitario Gregorio Marañón) ; García-Arocha, Jennifer (Hospital Nacional de Parapléjicos-SESCAM) ; Ortega, María Cristina (Hospital Nacional de Parapléjicos-SESCAM) ; Clemente, Diego (Hospital Nacional de Parapléjicos-SESCAM) ; Universitat Autònoma de Barcelona
The increasing number of treatments that are now available to manage patients with multiple sclerosis (MS) highlights the need to develop biomarkers that can be used within the framework of individualized medicine. [...]
2022 - 10.1186/s12974-022-02635-3
Journal of neuroinflammation, Vol. 19 (november 2022)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.